Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2016, Article ID 2178218, 4 pages
http://dx.doi.org/10.1155/2016/2178218
Clinico-Pathologic Conferences

Lichtheimia ramosa: A Fatal Case of Mucormycosis

1Pulmonary Department, Hospital Álvaro Cunqueiro, EOXI Vigo, NeumoVigoI+i Research Group, Vigo Biomedical Research Institute (IBIV), Estrada Clara Campoamor No. 341, 36312 Vigo, Spain
2Critical Care Department, Hospital Álvaro Cunqueiro, EOXI Vigo, Estrada Clara Campoamor No. 341, 36312 Vigo, Spain
3Pathology Department, Hospital Álvaro Cunqueiro, EOXI Vigo, Estrada Clara Campoamor No. 341, 36312 Vigo, Spain

Received 10 June 2015; Accepted 17 November 2015

Copyright © 2016 Cecilia Mouronte-Roibás et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Kutlu, Ç. Ergin, F. Bir et al., “Pulmonary mucormycosis due to Lichtheimia ramosa in a patient with HIV infection,” Mycopathologia, vol. 178, no. 1-2, pp. 111–115, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. G. R. Verma, D. R. Lobo, R. Walker, S. M. Bose, and K. L. Gupta, “Disseminated mucormycosis in healthy adults,” Journal of Postgraduate Medicine, vol. 41, no. 2, pp. 40–42, 1995. View at Google Scholar · View at Scopus
  3. F. Lanternier, E. Dannaoui, G. Morizot et al., “French Mycosis Study Group. A global analysis of mucormycosis in France: the RetroZygo Study (2005–2007),” Clinical Infectious Diseases, vol. 54, supplement 1, pp. S35–S43, 2012. View at Google Scholar
  4. B. Rammaert, F. Lanternier, J.-R. Zahar et al., “Healthcare-associated mucormycosis,” Clinical Infectious Diseases, vol. 54, supplement 1, pp. S44–S54, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. B. J. Ferguson, “Mucormycosis of the nose and paranasal sinuses,” Otolaryngologic Clinics of North America, vol. 33, no. 2, pp. 349–365, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Helenglass, J. A. Elliott, and N. P. Lucie, “An unusual presentation of opportunistic mucormycosis,” British Medical Journal, vol. 282, no. 6258, pp. 108–109, 1981. View at Google Scholar · View at Scopus
  7. R. Borrás, P. Roselló, M. Chilet, D. Bravo, J. G. de Lomas, and D. Navarro, “Positive result of the Aspergillus galactomannan antigen assay using bronchoalveolar lavage fluid from a patient with an invasive infection due to Lichtheimia ramosa,” Journal of Clinical Microbiology, vol. 48, no. 8, pp. 3035–3036, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Alastruey-Izquierdo, I. Cuesta, G. Walther, M. Cuenca-Estrella, and J. L. Rodríguez-Tudela, “Antifungal susceptibility profile of human-pathogenic species of Lichtheimia,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 7, pp. 3058–3060, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Spellberg, T. J. Walsh, D. P. Kontoyiannis, J. J. Edwards Jr., and A. S. Ibrahim, “Recent advances in the management of mucormycosis: from bench to bedside,” Clinical Infectious Diseases, vol. 48, no. 12, pp. 1743–1751, 2009. View at Publisher · View at Google Scholar · View at Scopus